Abridge names an 'unlimited enterprise agreement' alongside its per-clinician license
Abridge's site now advertises an unlimited enterprise agreement (CHRISTUS Health) beside the per-clinician default, consolidates to three product lines, and claims 300+ health systems.
Per-clinician (per-seat / PEPM-style) annual license as the only named contract shape; four modules (Clinician, Nursing, Revenue Cycle, CDS); site claimed 150+ health systems.
Per-clinician license plus a named 'unlimited enterprise agreement' that decouples price from headcount; three product lines (Clinicians, Nurses, Revenue Cycle) with contextual reasoning folded in as an AI capability; site claims 300+ health systems and pitches payers and life sciences alongside providers.
Abridge still publishes no prices — there is no /pricing page, and the contact page is a bare email-capture field. But the July 2026 capture shows the commercial model widening in three ways that matter to a buyer.
A second contract shape. A customer story on the Customers page is titled “Why CHRISTUS Health Expanded to an Unlimited Enterprise Agreement with Trusted AI Partner Abridge.” This is the first time Abridge’s own surfaces name a contract that is not counted per clinician. An unlimited, system-wide agreement is a site-license motion — it removes headcount from the invoice and changes the negotiation from “how many seats” to “how much is the system worth.” For a vendor whose whole model has been per-seat, that is a meaningful packaging fork, and it points at the pressure every ambient-scribe vendor faces: as the AI does more of the documentation work, seat counts stop tracking value.
Consolidated product lines. Site navigation now lists three products — Clinicians, Nurses, Revenue Cycle. The separately-described CDS module is gone as a line item; clinical decision support and the newly-available context-aware evidence feature (UpToDate, NEJM, JAMA, contextualized to the encounter) are now presented as platform capabilities rather than attachable modules. Fewer paid modules, more included platform.
A wider buyer. The homepage now describes Abridge as “one intelligence layer connecting health systems, payers, and life sciences organizations,” and the deployed-base claim moved from 150+ to 300+ health systems. Payers and life sciences do not buy clinician seats, which implies contract shapes Abridge has not yet described publicly.
No dollar figure appears on any Abridge surface. Third-party indicative per-clinician pricing remains third-party-reported and unconfirmed.
Abridge's own surfaces name a second contract shape for the first time — an 'unlimited enterprise agreement' (CHRISTUS Health) that decouples price from clinician headcount, sitting alongside the per-clinician license. Product lines consolidate from four to three (Clinicians, Nurses, Revenue Cycle) as the CDS module folds into the platform as context-aware evidence from UpToDate, NEJM and JAMA. The buyer frame widens from health systems to 'health systems, payers, and life sciences organizations' and the deployed-base claim moves from 150+ to 300+ health systems. Still no published price on any surface.